Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome

被引:82
|
作者
Ding, Haigang [1 ,2 ]
Zhang, Juan [1 ,2 ]
Zhang, Feng [1 ,2 ]
Zhang, Songou [3 ]
Chen, Xiaozhen [3 ]
Liang, Wenqing [4 ]
Xie, Qiong [5 ]
机构
[1] Shaoxing Matern & Child Hlth Care Hosp, Dept Gynecol, Shaoxing, Peoples R China
[2] Shaoxing Univ, Obstet & Gynecol Hosp, Shaoxing, Peoples R China
[3] Shaoxing Univ, Coll Med, Shaoxing, Peoples R China
[4] Zhejiang Chinese Med Univ, Med Res Ctr, Zhoushan Hosp Tradit Chinese Med, Zhoushan, Peoples R China
[5] Zhejiang Chinese Med Univ, Dept Gynecol, Zhoushan Hosp Tradit Chinese Med, Zhoushan, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2021年 / 12卷
关键词
polycystic ovary syndrome (PCOS); insulin resistance; androgen; hyper-androgenemia; endocrine disorder; IMPAIRED GLUCOSE-TOLERANCE; ANTI-MULLERIAN HORMONE; METABOLIC SYNDROME; DIABETES-MELLITUS; BIOCHEMICAL HYPERANDROGENISM; ENDOCRINE PARAMETERS; PREMENOPAUSAL WOMEN; MOLECULAR DEFECTS; CONCEPTION RATES; FOLLICULAR-FLUID;
D O I
10.3389/fendo.2021.741764
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PCOS has a wide range of negative impacts on women's health and is one of the most frequent reproductive systemic endocrine disorders. PCOS has complex characteristics and symptom heterogeneity due to the several pathways that are involved in the infection and the absence of a comm14on cause. A recent study has shown that the main etiology and endocrine aspects of PCOS are the increased level of androgen, which is also known as "hyperandrogenemia (HA)" and secondly the "insulin resistance (IR)". The major underlying cause of the polycystic ovary is these two IR and HA, by initiating the disease and its severity or duration. As a consequence, study on Pathogenesis is crucial to understand the effect of "HA" and "IR" on the pathophysiology of numerous symptoms linked to PCOS. A deep understanding of the pattern of the growth in PCOS for HA and IR can help ameliorate the condition, along with adjustments in nutrition and life, as well as the discovery of new medicinal products. However, further research is required to clarify the mutual role of IR and HA on PCOS development.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Insulin Resistance and Serum Magnesium Concentrations among Women with Polycystic Ovary Syndrome
    Hamilton, Kristen P.
    Zelig, Rena
    Parker, Anna R.
    Haggag, Amina
    CURRENT DEVELOPMENTS IN NUTRITION, 2019, 3 (11):
  • [42] The correlation of plasma homocysteine with insulin resistance in polycystic ovary syndrome
    Yilmaz, Nafiye
    Pektas, Mine
    Tonguc, Esra
    Kilic, Sevtap
    Gulerman, Cavidan
    Gungor, Tayfun
    Mollamahmutoglu, Leyla
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2008, 34 (03) : 384 - 391
  • [43] The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome
    Yilmaz, M
    Biri, A
    Karakoç, A
    Törüner, F
    Bingöl, B
    Çakir, N
    Tiras, B
    Ayvaz, G
    Arslan, M
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2005, 28 (11) : 1003 - 1008
  • [44] The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome
    M. Yilmaz
    A. Biri
    A. Karakoç
    F. Törüner
    B. Bingöl
    N. Çakir
    B. Tiras
    G. Ayvaz
    M. Arslan
    Journal of Endocrinological Investigation, 2005, 28 : 1003 - 1008
  • [45] Insulin and hyperandrogenism in women with polycystic ovary syndrome
    Baptiste, Catherine G.
    Battista, Marie-Claude
    Trottier, Andreanne
    Baillargeon, Jean-Patrice
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2010, 122 (1-3) : 42 - 52
  • [46] Identification of Differentially Expressed MicroRNAs in the Ovary of Polycystic Ovary Syndrome with Hyperandrogenism and Insulin Resistance
    Lin, Lin
    Du, Tao
    Huang, Jia
    Huang, Li-Li
    Yang, Dong-Zi
    CHINESE MEDICAL JOURNAL, 2015, 128 (02) : 169 - 174
  • [47] New markers of insulin resistance in polycystic ovary syndrome
    K. Polak
    A. Czyzyk
    T. Simoncini
    B. Meczekalski
    Journal of Endocrinological Investigation, 2017, 40 : 1 - 8
  • [48] Prediction models for insulin resistance in the polycystic ovary syndrome
    Gennarelli, G
    Holte, J
    Berglund, L
    Berne, C
    Massobrio, M
    Lithell, H
    HUMAN REPRODUCTION, 2000, 15 (10) : 2098 - 2102
  • [49] Insulin resistance in nonobese patients with polycystic ovary syndrome
    Toprak, S
    Yönem, A
    Çakir, B
    Güler, S
    Azal, Ö
    Özata, M
    Çorakçi, A
    HORMONE RESEARCH, 2001, 55 (02) : 65 - 70
  • [50] The role of miRNAs in polycystic ovary syndrome with insulin resistance
    Yingliu Luo
    Chenchen Cui
    Xiao Han
    Qian Wang
    Cuilian Zhang
    Journal of Assisted Reproduction and Genetics, 2021, 38 : 289 - 304